Evaluating diagnostic accuracy and determining optimal diagnostic thresholds of different approaches to [68Ga]-DOTATATE PET/MRI analysis in patients with meningioma
Authors:
- Michelle RoytmanMRMichelle Roytman
- Rajiv S. MaggeRMRajiv S. Magge
- Benjamin LiechtyBLBenjamin Liechty
- Rohan RamakrishnaRRRohan Ramakrishna
- Susan C. PannulloSPSusan C. Pannullo
- Theodore H. SchwartzTSTheodore H. Schwartz
- Nicolas A. KarakatsanisNKNicolas A. Karakatsanis
- Joseph R. OsborneJOJoseph R. Osborne
- Eaton LinELEaton Lin
- Jonathan P. S. KniselyJKJonathan P. S. Knisely
Open Access
- 3 June 2022
- journal article
- research article
- Published by Springer Nature in Scientific Reports
- Vol. 12 (1) , 1-12
Abstract
Multiple approaches with [68Ga]-DOTATATE, a somatostatin analog PET radiotracer, have demonstrated clinical utility in evaluation of meningioma but have not been compared directly. Our purpose was to compare diagnostic performance of different approaches to quantitative brain [68Ga]-DOTATATE PET/MRI analysis in patients with suspected meningioma recurrence and to establish the optimal diagnostic threshold for each method. Patients with suspected meningioma were imaged prospectively with [68Ga]-DOTATATE brain PET/MRI. Lesions were classified as meningiomas and post-treatment change (PTC), using follow-up pathology and MRI as reference standard. Lesions were reclassified using the following methods: absolute maximum SUV threshold (SUV), SUV ratio (SUVR) to superior sagittal sinus (SSS) (SUVRsss), SUVR to the pituitary gland (SUVRpit), and SUVR to the normal brain parenchyma (SUVRnorm). Diagnostic performance of the four methods was compared using contingency tables and McNemar’s test. Previously published pre-determined thresholds were assessed where applicable. The optimal thresholds for each method were identified using Youden’s J statistics. 166 meningiomas and 41 PTC lesions were identified across 62 patients. SUV, SUVRsss, SUVRpit, and SUVRnorm of meningioma were significantly higher than those of PTC (P < 0.0001). The optimal thresholds for SUV, SUVRsss, SUVRpit, and SUVRnorm were 4.7, 3.2, 0.3, and 62.6, respectively. At the optimal thresholds, SUV had the highest specificity (97.6%) and SUVRsss had the highest sensitivity (86.1%). An ROC analysis of SUV, SUVRsss, SUVRpit, and SUVRnorm revealed AUC of 0.932, 0.910, 0.915, and 0.800, respectively (P < 0.0001). Developing a diagnostic threshold is key to wider clinical translation of [68Ga]-DOTATATE PET/MRI in meningioma evaluation. We found that the SUVRsss method may have the most robust combination of sensitivity and specificity in the diagnosis of meningioma in the post-treatment setting, with the optimal threshold of 3.2. Future studies validating our findings in different patient populations are needed to continue optimizing the diagnostic performance of [68Ga]-DOTATATE PET/MRI in meningioma patients.Trial registration: ClinicalTrials.gov Identifier: NCT04081701. Registered 9 September 2019. https://clinicaltrials.gov/ct2/show/NCT04081701.Keywords
All Related Versions
Funding Information
- RSNA Research and Education Foundation
- Novartis Pharmaceuticals Corporation (CAAA501A0US05T)
This publication has 30 references indexed in Scilit:
- Somatostatin-receptor-targeted radionuclide therapy for progressive meningioma: benefit linked to68Ga-DOTATATE/-TOC uptakeNeuro-Oncology, 2016
- 68Gallium-DOTATATE PET in meningioma: A reliable predictor of tumor growth rate?Neuro-Oncology, 2016
- Impact of whole-body MRI in a general population studyEuropean Journal of Epidemiology, 2015
- Somatostatin Receptor Imaging with68Ga DOTATATE PET/CT: Clinical Utility, Normal Patterns, Pearls, and Pitfalls in InterpretationRadioGraphics, 2015
- Increased 68Ga-DOTATATE Uptake in PET Imaging Discriminates Meningioma and Tumor-Free TissueJournal of Nuclear Medicine, 2015
- Meningiomas: knowledge base, treatment outcomes, and uncertainties. A RANO reviewJournal of Neurosurgery, 2015
- Multiple meningioma with different grades of malignancy: Case report with genetic analysis applying single-nucleotide polymorphism array and classical cytogeneticsPathology - Research and Practice, 2011
- Potential impact of 68Ga-DOTATOC PET/CT on stereotactic radiotherapy planning of meningiomasEuropean Journal of Nuclear Medicine and Molecular Imaging, 2009
- Expression of c-Myc, neurofibromatosis Type 2, somatostatin receptor 2 and erb-B2 in human meningiomas: relation to grades or histotypesClinical Neuropathology, 2008
- New Classification Scheme for the Prognostic Stratification of Meningioma on the Basis of Chromosome 14 Abnormalities, Patient Age, and Tumor HistopathologyJournal of Clinical Oncology, 2003